EBOS Group Limited/Announcement
EBOS Group Limited logo

Ongoing Disclosure Notices – DRP shares

Insider Disclosure18 October 2019EBOHealthcare

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

EBOS Group Limited

Date this disclosure made:

18-Oct-19

Date of last disclosure:

13-May-19

Director or senior manager giving disclosure

Full name(s):

Elizabeth Coutts

Name of listed issuer:

EBOS Group Limited

Name of related body corporate (if applicable):

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary

Nature of the affected relevant interest(s):

Issue of shares pursuant to

dividend reinvestment plan

For that relevant interest-

Number held in class before acquisition or disposal:

32,500

Number held in class after acquisition or disposal:

32,865

Current registered holder(s):

N/A

Registered holder(s) once transfers are registered:

Como Nominees Limited

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-

Date of transaction:11-Oct-19

Nature of transaction:

Issue of shares pursuant to

dividend reinvestment plan

Name of any other party or parties to the transaction (if known):

The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:

$8,818.40

Number of financial products to which the transaction related: 365 ordinary shares

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

18-Oct-19

Name and title of authorised person:

Janelle Cain,

General Counsel

EBOS Group Limited


Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

EBOS Group Limited

Date this disclosure made:

18-Oct-19

Date of last disclosure:

9-Apr-19

Director or senior manager giving disclosure

Full name(s):

Sarah Ottrey

Name of listed issuer:

EBOS Group Limited

Name of related body corporate (if applicable):

N/A

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares

Nature of the affected relevant interest(s):

Issue of shares pursuant to

dividend reinvestment plan

For that relevant interest-

Number held in class before acquisition or disposal:

8176 ordinary shares

Number held in class after acquisition or disposal:

8268 ordinary shares

Current registered holder(s):

Sarah Christine Ottrey & Peter

Calder Groves

Registered holder(s) once transfers are registered:

Sarah Christine Ottrey & Peter

Calder Groves

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

N/A

Class of underlying financial products:

N/A

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

N/A

A statement as to whether the derivative is cash settled or physically settled:

N/A

Maturity date of the derivative (if any):

N/A

Expiry date of the derivative(if any):

N/A

The price specified in the terms of the derivative (if any):

N/A

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

N/A

For that derivative,-

Parties to the derivative:

N/A

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

N/A

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-

Date of transaction:11-Oct-19

Nature of transaction:

Issue of shares pursuant to

dividend reinvestment plan

Name of any other party or parties to the transaction (if known):N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:

$2,222.72

Number of financial products to which the transaction related: 92 ordinary shares

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:Ordinary shares

Nature of relevant interest:

Beneficial interest

For that relevant interest,-

Number held in class:3050 ordinary shares

Current registered holder(s):

FNZ Nominees Limited which

holds shares on behalf of The

Phil Ingham Family Trust

For a derivative relevant interest,-

Type of derivative:N/A

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

N/A

A statement as to whether the derivative is cash settled or physically settled:N/A

Maturity date of the derivative (if any):N/A

Expiry date of the derivative (if any):N/A

The price's specified terms (if any):N/A

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

N/A

For that derivative relevant interest,-

Parties to the derivative: N/A

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

18-Oct-19

Name and title of authorised person:

Janelle Cain, General Counsel,

EBOS Group Limited


Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

EBOS Group Limited

Date this disclosure made:

18-Oct-19

Date of last disclosure:

1-Oct-19

Director or senior manager giving disclosure

Full name(s):

Sean Duggan

Name of listed issuer:

EBOS Group Limited

Name of related body corporate (if applicable):

N/A

Position held in listed issuer:

CEO, Animal Care and Consumer Brands

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in EBOS Group Limited

Nature of the affected relevant interest(s):

Issue of shares pursuant to dividend

reinvestment plan

For that relevant interest-

Number held in class before acquisition or disposal:

305 ordinary shares

Number held in class after acquisition or disposal:

310 ordinary shares

Current registered holder(s):

Sean Duggan

Registered holder(s) once transfers are registered:

N/A

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

N/A

Class of underlying financial products:

N/A

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

N/A

A statement as to whether the derivative is cash settled or physically settled:

N/A

Maturity date of the derivative (if any):

N/A

Expiry date of the derivative(if any):

N/A

The price specified in the terms of the derivative (if any):

N/A

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products: N/A

For that derivative,-

Parties to the derivative:

N/A

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

N/A

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-

Date of transaction:

11-Oct-19

Nature of transaction:

Issue of shares pursuant to dividend

reinvestment plan

Name of any other party or parties to the transaction (if known):N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition

or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:

$120.80

Number of financial products to which the transaction related: 5 ordinary shares

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No

Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:Ordinary shares

Nature of relevant interest:

Registered holder - 2017 long term incentive

plan

For that relevant interest,-

Number held in class:

50,000 ordinary shares

Current registered holder(s):

Sean Duggan

For a derivative relevant interest,-

Type of derivative:

N/A

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial

products (if any):

N/A

A statement as to whether the derivative is cash settled or physically settled:

N/A

Maturity date of the derivative (if any):

N/A

Expiry date of the derivative (if any):

N/A

The price's specified terms (if any):

N/A

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

N/A

For that derivative relevant interest,-

N/A

Parties to the derivative:

N/A

If the director or senior manager is not a party to the derivative, the nature of the relevant

interest in the derivative:

N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

18-Oct-19

Name and title of authorised person:

Janelle Cain, General Counsel, EBOS Group

Limited

---

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 1


Rule 3.19A.2

Appendix 3Y


Change of Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11


Name of entity EBOS Group Limited

ABN N/A


We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for

the director for the purposes of section 205G of the Corporations Act.


Name of Director

Elizabeth Coutts

Date of last notice

13 May 2019


Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Direct or indirect interest

Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant

interest.


Beneficial ownership – registered owner is

Como Nominees Ltd

Date of change

11 October 2019

No. of securities held prior to change

32,500 ordinary shares

Class

Ordinary shares

Number acquired

365 ordinary shares

Number disposed

None

Value/Consideration

Note: If consideration is non-cash, provide details and estimated

valuation


NZ$8818.40

No. of securities held after change

32,865 ordinary shares

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


Appendix 3Y Page 2 01/01/2011


Nature of change

Example: on-market trade, off-market trade, exercise of options,

issue of securities under dividend reinvestment plan, participation in

buy-back

Issue of shares pursuant dividend

reinvestment plan.


Part 2 – Change of director’s interests in contracts


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should

be disclosed in this part.



Detail of contract


Nature of interest




Name of registered holder

(if issued securities)



Date of change


No. and class of securities to which

interest related prior to change

Note: Details are only required for a contract in

relation to which the interest has changed



Interest acquired


Interest disposed


Value/Consideration

Note: If consideration is non-cash, provide details

and an estimated valuation



Interest after change



Part 3 –

+

Closed period


Were the interests in the securities or contracts detailed

above traded during a

+

closed period where prior written

clearance was required?

No.

If so, was prior written clearance provided to allow the trade

to proceed during this period?


If prior written clearance was provided, on what date was this

provided?




Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


01/01/2011 Appendix 3Y Page 1


Rule 3.19A.2

Appendix 3Y


Change of Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11


Name of entity EBOS Group Limited

ABN N/A


We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for

the director for the purposes of section 205G of the Corporations Act.


Name of Director

Sarah Ottrey

Date of last notice

9 April 2019


Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Direct or indirect interest

Direct

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant

interest.



Date of change

11 October 2019

No. of securities held prior to change

• 8,176 ordinary shares /directly held

• 3,050 ordinary shares /beneficial interest

Class

Ordinary shares

Number acquired

92 ordinary shares

Number disposed

Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated

valuation


$2,222.72

No. of securities held after change

• Directly: 8,268 ordinary shares

• Indirectly: 3,050 ordinary shares

Appendix 3Y
Change of Director’s Interest Notice




+ See chapter 19 for defined terms.


Appendix 3Y Page 2 01/01/2011


Nature of change

Example: on-market trade, off-market trade, exercise of options,

issue of securities under dividend reinvestment plan, participation in

buy-back

Issue of shares pursuant to dividend

reinvestment plan


Part 2 – Change of director’s interests in contracts


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should

be disclosed in this part.



Detail of contract


Nature of interest




Name of registered holder

(if issued securities)



Date of change


No. and class of securities to which

interest related prior to change

Note: Details are only required for a contract in

relation to which the interest has changed



Interest acquired


Interest disposed


Value/Consideration

Note: If consideration is non-cash, provide details

and an estimated valuation



Interest after change



Part 3 –

+

Closed period


Were the interests in the securities or contracts detailed

above traded during a

+

closed period where prior written

clearance was required?

No.

If so, was prior written clearance provided to allow the trade

to proceed during this period?


If prior written clearance was provided, on what date was this

provided?

---

Appendix 3Z
Final Director’s Interest Notice




+ See chapter 19 for defined terms.


11/3/2002 Appendix 3Z Page 1

Rule 3.19A.3

Appendix 3Z


Final Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.


Name of entity EBOS Group Limited

ABN N/A


We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for

the director for the purposes of section 205G of the Corporations Act.


Name of director

Mark Waller

Date of last notice

9 April 2019

Date that director ceased to be director

15 October 2019


Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should

be disclosed in this part.


Number & class of securities


 Mark Brendon Waller & John Matthew Cullity as trustees of the EBOS Staff

Share Plan: 71,592 ordinary shares


 Mark Brendon Waller & Angela Laura Waller: 506,692 ordinary shares














Appendix 3Z
Final Director’s Interest Notice




+ See chapter 19 for defined terms.


Appendix 3Z Page 2 11/3/2002


Part 2 – Director’s relevant interests in securities of which the director is not the registered holder


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should

be disclosed in this part.


In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust


Name of holder & nature of interest

Note: Provide details of the

circumstances giving rise to the

relevant interest


N/A









Number & class of securities




Part 3 – Director’s interests in contracts


Detail of contract

N/A

Nature of interest



N/A

Name of registered holder

(if issued securities)


N/A

No. and class of securities to which

interest relates



N/A

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • BGP — Briscoe Group Limited: Ongoing Disclosure Notice
    2019-11-17

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure: Director or senior mana er ivin d…”

  • ENS — Enprise Group Limited: SPH Notice – Ronald Ivor Baskind
    2020-01-06

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Enprise Group Limited Date this disclosure made: 6-Jan-20 Date of last disclosure:…”

  • BGP — Briscoe Group Limited: Ongoing Disclosure Notice
    2019-11-14

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure: Director or senior mana er ivin d…”